top of page
Montain.png

The BariTon™

BariaTek first product candidate, the BariTon™, is a soft, atraumatic, reversible implant that is delivered via a simple endoscopy through the mouth within a few minutes and in an outpatient setting. It consists of a gastric part and an intestinal part, thereby having a dual effect: reduced food intake and reduced calorie absorption. The BariTon™ is expected to be the first implant of its kind to potentially mimic the efficacy of sleeve gastrectomy and bypass surgery and offer superior safety, ease of use, reversibility, and lower cost.

Human
Feasibility
Study

BariaTek Medical is conducting a human feasibility study in two sites:

  • The BMI Clinic in Sydney Australia with Dr Adrian Sartoretto, Principal Investigator and Bariatric Endoscopist.

  • The Republic Center of Surgery in Tashkent Uzbekistan with Dr Aburashid Abdukarimov, Principal Investigator and Bariatric Surgeon.

The goal of the human feasibility study is to assess the safety and efficacy of the BariTon™ in patients suffering from obesity at multiple time points and up to 1 year.

bottom of page